Glioma diagnosis and therapy: current challenges and nanomaterial-based solutions

T Li, J Li, Z Chen, S Zhang, S Li, S Wageh… - Journal of controlled …, 2022 - Elsevier
Glioma is often referred to as one of the most dreadful central nervous system (CNS)-specific
tumors with rapidly-proliferating cancerous glial cells, accounting for nearly half of the brain …

Pharmaceutical formulations with P-glycoprotein inhibitory effect as promising approaches for enhancing oral drug absorption and bioavailability

TTL Nguyen, VA Duong, HJ Maeng - Pharmaceutics, 2021 - mdpi.com
P-glycoprotein (P-gp) is crucial in the active transport of various substrates with diverse
structures out of cells, resulting in poor intestinal permeation and limited bioavailability …

Nanoparticle-based drug delivery systems to overcome gastric cancer drug resistance

K Nejati, M Rastegar, F Fathi, M Dadashpour… - Journal of Drug Delivery …, 2022 - Elsevier
Gastric cancer (GC) results from deregulated cell growth in the stomach. Despite significant
efforts and recent advancements in the treatment of gastric cancer, it remains a life …

Co-delivery of curcumin and paclitaxel by “core-shell” targeting amphiphilic copolymer to reverse resistance in the treatment of ovarian cancer

MD Zhao, JQ Li, FY Chen, W Dong… - International journal …, 2019 - Taylor & Francis
Background Ovarian cancer is a common malignancy in the female reproductive system with
a high mortality rate. The most important reason is multidrug resistance (MDR) of cancer …

Advancements in redox-sensitive micelles as nanotheranostics: a new horizon in cancer management

A Sikder, G Vambhurkar, E Amulya… - Journal of Controlled …, 2022 - Elsevier
Abstract World Health Organisation (WHO) delineated cancer as one of the foremost
reasons for mortality with 10 million deaths in the year 2020. Early diagnosis and effective …

[HTML][HTML] Recent advances in access to overcome cancer drug resistance by nanocarrier drug delivery system

X Sun, P Zhao, J Lin, K Chen, J Shen - Cancer Drug Resistance, 2023 - ncbi.nlm.nih.gov
Cancer is currently one of the most intractable diseases causing human death. Although the
prognosis of tumor patients has been improved to a certain extent through various modern …

Nanoparticles in Colorectal Cancer Therapy: Latest In Vivo Assays, Clinical Trials, and Patents

L Cabeza, G Perazzoli, C Mesas, C Jiménez-Luna… - AAPS …, 2020 - Springer
Colorectal cancer (CRC) is the third most common cancer worldwide. Its poor response to
current treatment options in advanced stages and the need for efficient diagnosis in early …

Overcoming colloidal nanoparticle aggregation in biological milieu for cancer therapeutic delivery: Perspectives of materials and particle design

SH Lim, TW Wong, WX Tay - Advances in Colloid and Interface Science, 2024 - Elsevier
Nanoparticles as cancer therapeutic carrier fail in clinical translation due to complex
biological environments in vivo consisting of electrolytes and proteins which render …

Polymeric micelles in cancer immunotherapy

Z Wan, R Zheng, P Moharil, Y Liu, J Chen, R Sun… - Molecules, 2021 - mdpi.com
Cancer immunotherapies have generated some miracles in the clinic by orchestrating our
immune system to combat cancer cells. However, the safety and efficacy concerns of the …

Acidic pH-Triggered Release of Doxorubicin from Ligand-Decorated Polymeric Micelles Potentiates Efficacy against Cancer Cells

S Maitra Roy, S Barman, P Kishore… - ACS Applied Nano …, 2023 - ACS Publications
Current chemotherapeutic strategies against various intractable cancers are futile due to
inefficient delivery, poor bioavailability, and inadequate accumulation of anticancer drugs in …